Concepedia

Mousumi Sannigrahi

MS

Statistics

Publications

20

Citations

898

H-Index

15

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Alberta

Mousumi Sannigrahi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and chemistry.

Publications per year

1994–2011

20

Publications

20

Stereocontrolled synthesis of spirocyclics

Mousumi Sannigrahi · Tetrahedron · 1999 · 312 citations

, , +11

Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor

Ashok Arasappan, Frank Bennett, Stéphane Bogen et al. · ACS Medicinal Chemistry Letters · 2010 · 98 citations

, , +15

Cyclic Sulfones as Novel P3-Caps for Hepatitis C Virus NS3/4A (HCV NS3/4A) Protease Inhibitors: Synthesis and Evaluation of Inhibitors with Improved Potency and Pharmacokinetic Profiles

Francisco Velázquez, Mousumi Sannigrahi, Frank Bennett et al. · Journal of Medicinal Chemistry · 2010 · 70 citations · Full text

, , +16

I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

G. Anilkumar, Charles A. Lesburg, Oleg Selyutin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 49 citations

, , +14

Stereoselective Synthesis of β-Substituted β-Amino Sulfones and Sulfonamides via Addition of Sulfonyl Anions to Chiral <i>N</i>-Sulfinyl Imines

Francisco Velázquez, Ashok Arasappan, Mousumi Sannigrahi et al. · Organic Letters · 2006 · 38 citations

, , +3

1–5 of 20